New Blood Pressure Medication Has Fewer Side Effects, Global Study Suggests
ScienceDaily (Apr. 1, 2008) — A major Canadian-led global study has found that a new blood pressure medication is effective in reducing cardiovascular death, with fewer side effects than the current standard of care. The study found a new drug telmisartan is as effective as the popular drug ramipril in reducing cardiovascular death in high risk patients and it has fewer side effects. Dr. Salim Yusuf, director of the Population Health Research Institute at McMaster University and Hamilton Health Sciences and principal investigator of the study, presented the results of ONTARGET March 31 at the American College of Cardiology conference. The paper has also been published on-line by the New England Journal of Medicine.